Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cancer Research UK, the UK Technology Strategy Board and pharmaceutical companies including AstraZeneca and Pfizer have launched 'Stratified Medicine Programme' to develop personalised cancer treatment.
Subscribe to our email newsletter
Through the initiative, development of a screening program to test tumours for major genetic changes will occur.
In addition, it will aid in genetic testing of both patients and tumours enabling the use of specialised drugs that target specific genes and mutations that can cause or influence the development of cancer.
The project will initially look at mutations in breast, bowel, lung, prostate as well as ovarian cancer and melanoma.